Nowlan Selvapatt

711 total citations
19 papers, 382 citations indexed

About

Nowlan Selvapatt is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Nowlan Selvapatt has authored 19 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Hepatology and 2 papers in Surgery. Recurrent topics in Nowlan Selvapatt's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (7 papers) and Liver Disease and Transplantation (5 papers). Nowlan Selvapatt is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (7 papers) and Liver Disease and Transplantation (5 papers). Nowlan Selvapatt collaborates with scholars based in United Kingdom, United States and Australia. Nowlan Selvapatt's co-authors include Ashley Brown, Sanjay Gautama, Charles Vincent, Shabnam Undre, Ara Darzi, Maria Koutantji, Nick Sevdalis, Samantha Williams, Peter McCulloch and Mark Thursz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Gut.

In The Last Decade

Nowlan Selvapatt

18 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nowlan Selvapatt United Kingdom 8 179 147 123 74 61 19 382
Henk W. van Hamersvelt Netherlands 11 103 0.6× 84 0.6× 45 0.4× 14 0.2× 40 0.7× 28 404
Roberta Petrino Italy 11 101 0.6× 115 0.8× 50 0.4× 17 0.2× 60 1.0× 28 517
Neil Kothari United States 11 158 0.9× 60 0.4× 100 0.8× 22 0.3× 18 0.3× 28 519
P. A. McVay United States 10 109 0.6× 122 0.8× 140 1.1× 10 0.1× 18 0.3× 13 633
François Martin Carrier Canada 12 94 0.5× 107 0.7× 308 2.5× 8 0.1× 16 0.3× 55 501
Alyson Kaplan United States 12 266 1.5× 244 1.7× 184 1.5× 15 0.2× 4 0.1× 34 481
Felipe Pareja-Ciuró Spain 13 113 0.6× 87 0.6× 258 2.1× 11 0.1× 7 0.1× 56 469
Ghulam Hassan Malik Saudi Arabia 12 90 0.5× 42 0.3× 80 0.7× 8 0.1× 22 0.4× 27 312
Ka‐Foon Chau China 12 102 0.6× 17 0.1× 47 0.4× 12 0.2× 48 0.8× 37 434
Donald L. Helman United States 11 86 0.5× 11 0.1× 75 0.6× 226 3.1× 76 1.2× 18 638

Countries citing papers authored by Nowlan Selvapatt

Since Specialization
Citations

This map shows the geographic impact of Nowlan Selvapatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nowlan Selvapatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nowlan Selvapatt more than expected).

Fields of papers citing papers by Nowlan Selvapatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nowlan Selvapatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nowlan Selvapatt. The network helps show where Nowlan Selvapatt may publish in the future.

Co-authorship network of co-authors of Nowlan Selvapatt

This figure shows the co-authorship network connecting the top 25 collaborators of Nowlan Selvapatt. A scholar is included among the top collaborators of Nowlan Selvapatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nowlan Selvapatt. Nowlan Selvapatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vithayathil, Mathew, Maria Qurashi, Ali Alsafi, et al.. (2024). Prospective Study of Non-Contrast, Abbreviated MRI for Hepatocellular Carcinoma Surveillance in Patients with Suboptimal Hepatic Visualisation on Ultrasound. Cancers. 16(15). 2709–2709. 1 indexed citations
2.
Auger, Stephen D., et al.. (2024). Methotrexate for the neurologist. Practical Neurology. 24(5). 369–375. 1 indexed citations
4.
Nathwani, Rooshi, et al.. (2021). Review of Rifaximin: A Summary of the Current Evidence and Benefits Beyond Licensed Use. SHILAP Revista de lepidopterología. 94–100. 2 indexed citations
5.
Forlano, Roberta, Benjamin H. Mullish, Sujit Mukherjee, et al.. (2020). In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19. PLoS ONE. 15(10). e0240400–e0240400. 51 indexed citations
6.
Mohamed, Zameer, Nick Scott, Deyaa Al‐Kurdi, et al.. (2020). Cost‐effectiveness of strategies to improve HCV screening, linkage‐to‐care and treatment in remand prison settings in England. Liver International. 40(12). 2950–2960. 9 indexed citations
7.
Mohamed, Zameer, Deyaa Al‐Kurdi, Margaret K. Nelson, et al.. (2019). Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England. International Journal of Drug Policy. 75. 102608–102608. 48 indexed citations
8.
McEwan, Phil, Nowlan Selvapatt, Ashley Brown, et al.. (2016). A clinician’s guide to the cost and health benefits of hepatitis C cure assessed from the individual patient perspective. European Journal of Gastroenterology & Hepatology. 29(2). 208–214. 4 indexed citations
9.
Selvapatt, Nowlan, et al.. (2016). Cost-Effectiveness of Birth Cohort Screening and Treatment for HCV in the UK: An Exploratory Analysis. Journal of Hepatology. 64(2). S465–S465. 1 indexed citations
10.
Selvapatt, Nowlan, et al.. (2016). The cost impact of outreach testing and treatment for hepatitis C in an urban Drug Treatment Unit. Liver International. 37(3). 345–353. 18 indexed citations
11.
Selvapatt, Nowlan, et al.. (2015). Hepatocellular Carcinoma Surveillance. Journal of Clinical Gastroenterology. 50(1). e8–e12. 12 indexed citations
12.
Selvapatt, Nowlan, Thomas Ward, Heather Bailey, et al.. (2015). Is antenatal screening for hepatitis C virus cost-effective? A decade’s experience at a London centre. Journal of Hepatology. 63(4). 797–804. 35 indexed citations
13.
Selvapatt, Nowlan, L. Harrison, & Ashley N. Brown. (2015). PTU-109 A pilot study of outreach testing for hepatitis C and linkage to care in a london centre for homeless persons. A109.2–A109. 3 indexed citations
14.
Selvapatt, Nowlan, Maximillian S. Habibi, & Ashley Brown. (2015). A European single centre experience of management of hepatitis C virus genotype 4 infection with pegylated-interferon and ribavirin. Journal of Medical Virology. 87(10). 1716–1721. 2 indexed citations
15.
Selvapatt, Nowlan, Arjuna Singanayagam, Julia Wendon, & Charalambos G. Antoniades. (2014). Understanding infection susceptibility in patients with acute-on-chronic liver failure. Intensive Care Medicine. 40(9). 1363–1366. 18 indexed citations
16.
Nayagam, Shevanthi, Nowlan Selvapatt, Horace R. Williams, et al.. (2012). OC-138 Quality of colonoscopic procedures among independently practising gastroenterology trainees in a NW London cohort: are they reaching national standards?. Gut. 61(Suppl 2). A59.3–A60. 1 indexed citations
17.
Selvapatt, Nowlan, James Barry, & Paul R. Roberts. (2009). Pyoderma gangrenosum complicating an implantable cardioverter defibrillator wound in a patient with ulcerative colitis. EP Europace. 11(11). 1482–1482. 7 indexed citations
18.
Zacharakis, Emmanouil, Joseph Shalhoub, Nowlan Selvapatt, Ara Darzi, & Paul Ziprin. (2009). Revisional laparoscopic parastomal hernia repair.. PubMed. 12(4). 403–6. 4 indexed citations
19.
Undre, Shabnam, Maria Koutantji, Nick Sevdalis, et al.. (2007). Multidisciplinary Crisis Simulations: The Way Forward for Training Surgical Teams. World Journal of Surgery. 31(9). 1843–1853. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026